AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMINO ACIDS
6 registrations across 4 African markets— 5 active
Markets with AMINO ACIDS
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Smofkabiven 1100 Emulsion for injection/ infusion | 🇿🇲Zambia | FRESENIUS KABI SOUTH AFRICA (PTY) LIMITED | active | Jul 2029 |
| CELEMIN INFUSION | 🇬🇭Ghana | — | active | Jul 2029 |
| CELEMIN INFUSION | 🇬🇭Ghana | — | active | Jul 2029 |
| DXN SPIRULINA TABLETS Tablet Uncoated | 🇿🇲Zambia | DXN | active | Aug 2028 |
| Bio-Aminosol** Powder | 🇳🇬Nigeria | Mikson Industries Limited | active | Jan 2027 |
| NUTRINEAL PD4 WITH 1.1 % AMINO ACIDS | 🇿🇦South Africa | Adcock Ingram Critical Care (Pty) Ltd | suspended | Sept 2022 |
AMINO ACIDS in Africa — Regulatory Overview
AMINO ACIDS is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Zambia, Nigeria, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 5 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.